Evidence map›Paper›PMID 26096609›Full record

Trial reportHeart rhythm2015

SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.

Wan-Tai M Au-Yeung, Per G Reinhall, Jeanne E Poole, Jill Anderson, George Johnson, Ross D Fletcher, Hans J Moore, Daniel B Mark, Kerry L Lee, Gust H Bardy

Erratum issuedAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Heart rhythm, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Association of non-linear dynamics of heart rate variability with all-cause mortality in patients with sarcoidosis.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Combining noninvasive risk stratification parameters improves the prediction of mortality and appropriate ICD shocks.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2019
    Article
  12. Article
  13. Review
  14. Article
  15. Predicting the risk of sudden cardiac death.The Journal of physiology · 2016
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Wan-Tai M Au-YeungUniversity of Washington, Seattle, Washington. Electronic address: wantai@uw.edu.
Per G ReinhallUniversity of Washington, Seattle, Washington.
Jeanne E PooleUniversity of Washington, Seattle, Washington.
Jill AndersonSeattle Institute for Cardiac Research, Seattle, Washington.
George JohnsonSeattle Institute for Cardiac Research, Seattle, Washington.
Ross D FletcherWashington DC Veterans Administration Medical Center, Washington, District of Columbia.
Hans J MooreWashington DC Veterans Administration Medical Center, Washington, District of Columbia.
Daniel B MarkDuke University, Durham, North Carolina.
Kerry L LeeDuke University, Durham, North Carolina.
Gust H BardyUniversity of Washington, Seattle, Washington; Seattle Institute for Cardiac Research, Seattle, Washington.
University of Washington · USDuke University · USThe Seattle Institute for Cardiac Research · USWashington DC VA Medical Center · US

Funding

DATA COORDINATING CENTER FOR SCD IN HEART FAILURE TRIALU01HL055297 · NHLBI · DUKE UNIVERSITY · PI LEE, KERRY L · 1997 to 2003
$3.2M
NHLBI NIH HHS U01 HL055297
6 · The paper itself

Abstract

backgroundIn the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT), a significant fraction of the patients with congestive heart failure ultimately did not die suddenly of arrhythmic causes. Patients with CHF will benefit from better tools to identify if implantable cardioverter-defibrillator (ICD) therapy is needed.

objectivesWe aimed to identify predictor variables from baseline SCD-HeFT patients' R-R intervals that correlate to arrhythmic sudden cardiac death (SCD) and mortality and to design an ICD therapy screening test.

methodsTen predictor variables were extracted from prerandomization Holter data from 475 patients enrolled in the ICD arm of the SCD-HeFT by using novel and traditional heart rate variability methods. All variables were correlated to SCD using the Mann-Whitney-Wilcoxon test and receiver operating characteristic analysis. ICD therapy screening tests were designed by minimizing the cost of false classifications. Survival analysis, including log-rank test and Cox models, was also performed.

resultsA short-term fractal exponent, α1, and a long-term fractal exponent, α2, from detrended fluctuation analysis, the ratio of low- to high-frequency power, the number of premature ventricular contractions per hour, and the heart rate turbulence slope are all statistically significant for predicting the occurrences of SCD (P < .001) and survival (log-rank, P < .01). The most powerful multivariate predictor tool using the Cox proportional hazards regression model was α2 with a hazard ratio of 0.0465 (95% confidence interval 0.00528-0.409; P < .01).

conclusionPredictor variables extracted from R-R intervals correlate to the occurrences of SCD and distinguish survival functions among patients with ICDs in SCD-HeFT. We believe that SCD prediction models should incorporate Holter-based R-R interval analysis to refine ICD patient selection, especially to exclude patients who are unlikely to benefit from ICD therapy.

Indexed as

Electrocardiography, AmbulatoryAdultAgedAged, 80 and overAmiodaroneAnti-Arrhythmia AgentsArrhythmias, CardiacDeath, Sudden, CardiacDefibrillators, ImplantableFemaleFollow-Up StudiesHeart FailureHeart RateHumansMaleMiddle AgedAmiodaroneAnti-Arrhythmia AgentsDetrended fluctuation analysisHeart failureHeart rate turbulenceHeart rate variabilityImplantable cardioverter-defibrillatorsNonlinear dynamicsSudden cardiac death

Identifiers

PMID26096609
PMCPMC4583791
OpenAlexW1870507185

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.